CASI

CASI is a biopharmaceutical company listed on the NASDAQ in the United States. Its platform aims to develop and accelerate the launch of pharmaceuticals and innovative therapies in China, the United States, and globally. The company has an office in Rockville, Maryland, and a wholly-owned subsidiary in Beijing, China, through which most of its operations are conducted.CASI is committed to developing and delivering high-quality pharmaceuticals and innovative therapies to global patients while focusing on the Chinese market. They concentrate on acquiring, licensing, developing, and commercializing products that address unmet medical needs. Their strategy is to leverage their regulatory and commercial capabilities in China along with their global expertise in drug development to become a leading platform for launching drugs in Greater China.